A Nutritional Supplement to Support People With Non-small Cell Lung Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

December 19, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Non-small Cell Lung Cancer
Interventions
DIETARY_SUPPLEMENT

Nutritional supplement

Subjects will orally consume two gelatin capsules of nutritional supplement (1 gram), 2 times per day with meals, and 1 capsule at one additional meal or snack, totaling five capsules per day beginning the first day of treatment and continuing for the duration of their treatment.

OTHER

Placebo

Subjects will orally consume two gelatin capsules of placebo (1 gram), 2 times per day with meals, and 1 capsule at one additional meal or snack, totaling five capsules per day beginning the first day of treatment and continuing for the duration of their treatment.

Trial Locations (1)

T6G 1Z2

Cross Cancer Institute, Edmonton

All Listed Sponsors
lead

AHS Cancer Control Alberta

OTHER